Concord Biotech548.20
+0.00 (-1.47%)

Concord Biotech Share Price

548.20+0.00 (-1.47%)
-23.21% past 1 Year

Corporate filings & documents

Announcements

Intimation of allotment of Bonus equity Shares
2 weeks ago
Intimation of allotment of Bonus equity Shares
2 weeks ago
Transcript of Q2 - FY27 Earnings call held on October 28 2026
2 weeks ago
Transcript of Q2 - FY27 Earnings call held on October 28 2026
2 weeks ago
Earning Call Recording- For the Second Quarter and half year ended on September 30 2026
3 weeks ago
Earning Call Recording- For the Second Quarter and half year ended on September 30 2026
3 weeks ago
Earning Call Recording- For the Second Quarter and half year ended on September 30 2026
3 weeks ago
Earning Call Recording- For the Second Quarter and half year ended on September 30 2026
3 weeks ago
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 to be held on 03rd and 4th November 2026.
3 weeks ago
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 to be held on 03rd and 4th November 2026.
3 weeks ago
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 to be held on 03rd and 4th November 2026.
3 weeks ago
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 to be held on 03rd and 4th November 2026.
3 weeks ago
Press release - For the Second quarter and half year ended on September 30 2026
3 weeks ago
Press release - For the Second quarter and half year ended on September 30 2026
3 weeks ago
Press release - For the Second quarter and half year ended on September 30 2026
3 weeks ago
Press release - For the Second quarter and half year ended on September 30 2026
3 weeks ago
Investors presentation on unaudited standalone and consolidated financial results for the second quarter and half year ended on September 30 2026
3 weeks ago
Investors presentation on unaudited standalone and consolidated financial results for the second quarter and half year ended on September 30 2026
3 weeks ago
Investors presentation on unaudited standalone and consolidated financial results for the second quarter and half year ended on September 30 2026
3 weeks ago
Investors presentation on unaudited standalone and consolidated financial results for the second quarter and half year ended on September 30 2026
3 weeks ago
The Board of Directors at its meeting held on October 27 2026 has fixed Wednesday November 04 2026 as record date for issuance of Bonus equity shares in the ratio of 1:1.
3 weeks ago
The Board of Directors at its meeting held on October 27 2026 has fixed Wednesday November 04 2026 as record date for issuance of Bonus equity shares in the ratio of 1:1.
3 weeks ago
The Board of Directors at its meeting held on October 27 2026 has fixed Wednesday November 04 2026 as record date for issuance of Bonus equity shares in the ratio of 1:1.
3 weeks ago
The Board of Directors at its meeting held on October 27 2026 has fixed Wednesday November 04 2026 as record date for issuance of Bonus equity shares in the ratio of 1:1.
3 weeks ago
Unaudited Standalone and Consolidated Financial Results for the second quarter and half year ended on September 30 2026.
3 weeks ago
Unaudited Standalone and Consolidated Financial Results for the second quarter and half year ended on September 30 2026.
3 weeks ago
Unaudited Standalone and Consolidated Financial Results for the second quarter and half year ended on September 30 2026.
3 weeks ago
Unaudited Standalone and Consolidated Financial Results for the second quarter and half year ended on September 30 2026.
3 weeks ago
The Board of Directors of the Company at its meeting held today i.e. Tuesday October 27 2026 has inter-alia considered and approved the Un-audited financial results for the quarter and half year ended September 30 2026 Record date for issue of Bonus equity shares and reconstituted committees of Board.
3 weeks ago
The Board of Directors of the Company at its meeting held today i.e. Tuesday October 27 2026 has inter-alia considered and approved the Un-audited financial results for the quarter and half year ended September 30 2026 Record date for issue of Bonus equity shares and reconstituted committees of Board.
3 weeks ago
The Board of Directors of the Company at its meeting held today i.e. Tuesday October 27 2026 has inter-alia considered and approved the Un-audited financial results for the quarter and half year ended September 30 2026 Record date for issue of Bonus equity shares and reconstituted committees of Board.
3 weeks ago
The Board of Directors of the Company at its meeting held today i.e. Tuesday October 27 2026 has inter-alia considered and approved the Un-audited financial results for the quarter and half year ended September 30 2026 Record date for issue of Bonus equity shares and reconstituted committees of Board.
3 weeks ago
Submission of Scrutinizers report and Voting Results of Postal Ballot dated September 23 2026
3 weeks ago
Submission of Scrutinizers report and Voting Results of Postal Ballot dated September 23 2026
3 weeks ago
Submission of Scrutinizers report and Voting Results of Postal Ballot dated September 23 2026
3 weeks ago
Earnings Call Invite for the operational and financial performance of the Company for the Quarter and half year ended on September 30 2026
1 month ago
Earnings Call Invite for the operational and financial performance of the Company for the Quarter and half year ended on September 30 2026
1 month ago
Concord Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2026 inter alia to consider and approve unaudited Standalone and Consolidated Financial Results for the second quarter and half year ended on September 30 2026 along with Limited Review Report thereon
1 month ago
Concord Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2026 inter alia to consider and approve unaudited Standalone and Consolidated Financial Results for the second quarter and half year ended on September 30 2026 along with Limited Review Report thereon
1 month ago
In compliance with regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 we furnish herewith certificate received from RTA of the Company.
1 month ago
Pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 as amended from time to time and as per the Companys Code of Conduct for Regulating Monitoring and Reporting of Trading by Insiders the trading window for trading in equity shares of the Company will be closed from October 01 2026 till the expiry of 48 hours after the declaration of the Unaudited Financial Results for the quarter and half year ended September 30 2026.
1 month ago
Pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 as amended from time to time and as per the Companys Code of Conduct for Regulating Monitoring and Reporting of Trading by Insiders the trading window for trading in equity shares of the Company will be closed from October 01 2026 till the expiry of 48 hours after the declaration of the Unaudited Financial Results for the quarter and half year ended September 30 2026.
1 month ago
Newspaper advertisement for Notice of Postal Ballot dated September 23 2026 and Remote E-Voting Information
1 month ago
Newspaper advertisement for Notice of Postal Ballot dated September 23 2026 and Remote E-Voting Information
1 month ago
Pursuant to regulation 30 of the SEBI (LODR) Regulations 2015 please find enclosed herewith a copy of the Postal Ballot Notice dated September 23 2026 together with explanatory statement thereto.
1 month ago
Pursuant to regulation 30 of the SEBI (LODR) Regulations 2015 please find enclosed herewith a copy of the Postal Ballot Notice dated September 23 2026 together with explanatory statement thereto.
1 month ago
The Board of Director at its meeting held today i.e. Wednesday September 23 2026 has inter-alia considered and approved Issuance of Bonus shares & Increase in the Authorised Share Capital of the Company and consequent amendment to Clause V regarding Authorised Share Capital of Memorandum of Association of the Company.
2 months ago
The Board of Director at its meeting held today i.e. Wednesday September 23 2026 has inter-alia considered and approved Issuance of Bonus shares & Increase in the Authorised Share Capital of the Company and consequent amendment to Clause V regarding Authorised Share Capital of Memorandum of Association of the Company.
2 months ago
Concord Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/09/2026 inter alia to consider and approve the proposal for declaration of bonus equity shares to the existing equity shareholders of the Company in accordance with the applicable provisions subject to approval of the shareholders of the Company.
2 months ago
Concord Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/09/2026 inter alia to consider and approve the proposal for declaration of bonus equity shares to the existing equity shareholders of the Company in accordance with the applicable provisions subject to approval of the shareholders of the Company.
2 months ago

Concalls & investor presentations

Oct 2026
ConcallPresentation
Oct 2026
Aug 2026
ConcallPresentation
Jul 2026
Jun 2026
ConcallPresentation
May 2026
Feb 2026
ConcallPresentation
Feb 2026
Aug 2025
ConcallPresentation
Aug 2025
May 2025
Feb 2025
ConcallPresentation
Feb 2025
Nov 2024
ConcallPresentation
Nov 2024
Aug 2024
ConcallPresentation
Aug 2024
May 2024
ConcallPresentation
May 2024
Feb 2024
ConcallPresentation
Feb 2024
Nov 2023
ConcallPresentation
Nov 2023
Sept 2023

Concord Biotech Ltd Share Price Today

The Concord Biotech Ltd share price today is ₹1367.5. During the trading session, the Concord Biotech Ltd share price opened at ₹1373.6 and recorded an intraday high of ₹1386.8 and a low of ₹1320. Last closing price was ₹1373.6. Over the past 52 weeks, the Concord Biotech Ltd share price has ranged between ₹987 and ₹1667.6. The current Concord Biotech Ltd stock price reflects real-time market activity based on executed trades on the exchange.